Loeb S.
” Active Surveillance Offers Functional Advantages Without Impacting Survival for Low-risk Prostate Cancer.”
European Urology. 2017 Nov 20. PMID: 29169932
Loeb S.
” Active Surveillance Offers Functional Advantages Without Impacting Survival for Low-risk Prostate Cancer.”
European Urology. 2017 Nov 20. PMID: 29169932